Adipose Tissue Disorders and Quality of Life

Adipose tissue disorders encompass a spectrum of conditions in which the distribution, composition or function of fat depots is altered, leading to chronic pain, impaired mobility and psychosocial burden. Lipedema, Dercum’s disease and localized hypertrophy syndromes are characterised by disproportionate subcutaneous fat accumulation, inflammatory changes and, in some cases, fibrotic remodelling. Patients frequently experience pain, tenderness and heaviness in the affected regions, alongside fatigue, disturbed sleep and mood disturbances. Misdiagnosis as obesity or lymphatic disease is common, delaying appropriate management and compounding distress. Recent advances have shed light on the cellular heterogeneity of adipose depots, the role of immune–stromal interactions and the impact of lymphatic function on tissue homeostasis. Quality of life is profoundly affected by chronic pain, functional limitations and body image concerns, emphasising the need for early recognition, multidisciplinary care pathways and patient-centred outcome measures. Globally, these disorders impose substantial healthcare costs and highlight the importance of tailored diagnostic criteria, novel biomarkers and targeted interventions to alleviate symptoms and restore well-being.

Research from Nature Portfolio

A foundational study has characterised the lymphatic and vascular milieu in lipedema, revealing elevated circulating levels of vascular endothelial growth factor C alongside marked macrophage infiltration in skin and fat biopsies. Despite increased pro-lymphangiogenic signals, no overt morphological changes to lymphatic vessel structure were observed, indicating a preserved lymphatic network. Instead, a distinct local cytokine profile—marked by reduced VEGF-A and VEGF-D expression—suggests that altered vascular permeability and immune cell recruitment drive tissue remodelling. These findings differentiate lipedema from classical lymphedema and offer mechanistic insights for biomarker development and anti-inflammatory strategies.

Adipose Tissue Disorders and Quality of Life publication trend

The graph below shows the total number of articles in adipose tissue disorders and quality of life across all publications each year (not limited to Nature Index journals).

Technical terms

Adipocyte hypertrophy: Enlargement of fat cells due to excess lipid accumulation.

Interstitial fibrosis: Excess deposition of collagen and extracellular matrix between tissue cells.

Macrophage infiltration: Recruitment of immune cells into adipose tissue, influencing inflammation and remodelling.

Vascular endothelial growth factor C (VEGF-C): A protein promoting the growth and permeability of lymphatic vessels.

Single-cell RNA sequencing: A technique that profiles gene expression in individual cells to reveal population heterogeneity.

Quality of life: A multidimensional measure of physical, psychological and social well-being reported by patients.

References

1. Lipedema stage affects adipocyte hypertrophy, subcutaneous adipose tissue inflammation and interstitial fibrosis. Frontiers in Immunology (2023).
2. Preliminary Single-Cell RNA-Sequencing Analysis Uncovers Adipocyte Heterogeneity in Lipedema. Cells (2024).
3. Increased levels of VEGF-C and macrophage infiltration in lipedema patients without changes in lymphatic vascular morphology. Scientific Reports (2020).
4. Modified Mediterranean-Ketogenic Diet and Carboxytherapy as Personalized Therapeutic Strategies in Lipedema: A Pilot Study. Nutrients (2023).
5. Quality of life, its factors, and sociodemographic characteristics of Polish women with lipedema. BMC Women's Health (2021).
6. Review of Dercum’s disease and proposal of diagnostic criteria, diagnostic methods, classification and management. Orphanet Journal of Rare Diseases (2012).